J. Benjamin Guise

Researcher

UAMS

Faculty Researcher

7 h-index 14 pubs 212 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

J. Benjamin Guise's research focuses on the pharmacological management of opioid use disorder and related conditions. His work investigates the efficacy of medications, such as gabapentin, in conjunction with opioid substitution treatments like buprenorphine and naltrexone. Guise has published studies examining gabapentin's role during outpatient buprenorphine tapers, particularly in the context of fentanyl exposure, and its combined effects with other agents in individuals maintained on methadone. His publications include randomized, placebo-controlled trials and studies utilizing novel-response discrimination procedures to understand drug effects in humans. Guise has a publication record of 14 papers with 209 citations and an h-index of 7. He has collaborated on multiple projects with researchers at the University of Arkansas for Medical Sciences, including Michael J. Mancino, Alison Oliveto, Jeff D. Thostenson, and Azizi Ray.

Metrics

h-index: 7
Publications: 14
Citations: 212

Selected Publications

Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025)

The American Journal of Drug and Alcohol Abuse 1 citation DOI OpenAlex
Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure (2025)

Behavioural Pharmacology DOI OpenAlex
THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN (2024)

Drug and Alcohol Dependence DOI OpenAlex
Psychometric Properties of the Copenhagen Burnout Inventory in an Academic Healthcare Institution Sample in the U.S. (2020)

Evaluation & the Health Professions 63 citations DOI OpenAlex
A One-Year Institutional View of Resident Physician Burnout (2019)

Academic Psychiatry 36 citations DOI OpenAlex
Improving buprenorphine treatment outcomes with the L-type calcium channel blocker isradipine (2017)

Drug and Alcohol Dependence DOI OpenAlex
Impact of lisdexamfetamine on retention of methamphetamine-dependent patients in a residential facility (2017)

Drug and Alcohol Dependence 2 citations DOI OpenAlex
Efficacy and tolerability of doxazosin in psychostimulant-dependent patients (2015)

Drug and Alcohol Dependence 1 citation DOI OpenAlex
What Do Medical Students Perceive as Meaningful in the Psychiatry Clerkship Learning Environment? A Content Analysis of Critical Incident Narratives (2015)

Academic Psychiatry 10 citations DOI OpenAlex
Cognitive and cardiovascular effects of carvedilol in recently abstinent, cocaine-dependent patients (2014)

Drug and Alcohol Dependence DOI OpenAlex
Clinical Efficacy of Sertraline Alone and Augmented With Gabapentin in Recently Abstinent Cocaine-Dependent Patients With Depressive Symptoms (2014)

Journal of Clinical Psychopharmacology 38 citations DOI OpenAlex
Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure (2013)

European Journal of Pharmacology 7 citations DOI OpenAlex
Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. (2013)

Experimental and Clinical Psychopharmacology 40 citations DOI OpenAlex